Corteria Pharmaceuticals

0 followers


Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.

Headquarters

Paris, France

Employees

1-10

Links


Org chart

Francesca Lawson
Chief Medical Officer
Stephane Durant Des Aulnois
Chief Financial Officer
Mark Pruzanski
Chairman Of The Board

Teams

This company has no teams yet